Recovery Should Not Have to Pause for Pregnancy — A Time for Special Care

By Mike Derkacz, President & CEO
May 5, 2026
Pregnancy and Recovery

Did you know opioid use disorder (OUD) affects about 1 in 40 pregnancies in the United States?1 That’s a significant number of people navigating one of the most physically and emotionally demanding experiences of their lives during their recovery journey.

Pregnancy and postpartum bring profound change. Hormonal shifts, physical demands, sleepless nights, and the weight of new responsibilities can all affect mental and emotional well-being. For individuals living with OUD, these stages can make the recovery journey difficult. The support systems and routines that help people stay on track don’t always account for the unique needs during pregnancy and early motherhood — and that gap matters.

That’s exactly why the MOMs study is so important.

Funded by the National Institutes of Health (NIH), the MOMs study is a landmark clinical trial designed to better understand how to support patients with OUD during pregnancy and postpartum. When a parent is supported during these demanding times, it can improve their chance of staying on track in their recovery journey.

At Braeburn, we’re proud to stand behind research that reflects what we’ve always believed: that informed, evidence-based care belongs to everyone — including those who are pregnant or postpartum. Recovery is possible at every stage of life, and, with the right support system, more people can experience it.

References

  1. Roberts T, Frederiksen B, Saunders H, et al . Opioid use disorder and treatment among pregnant and postpartum Medicaid enrollees. KFF. Published September 19, 2023. Accessed April 16, 2026. https://www.kff.org/medicaid/opioid-use-disorder-and-treatment-among-pregnant-and-postpartum-medicaid-enrollees/.